We are pleased to share the recording of our recent webinar held in collaboration with Kartos Therapeutics, featuring Dr. Serge Verstovsek, Kartos’ Chief Medical Officer and a leading expert in myeloproliferative neoplasms.

In this session, Dr. Verstovsek provided valuable insights into the POIESIS trial – a newly launched, global Phase 3 clinical study designed for patients living with myelofibrosis. The study spans 221 hospitals across the USA, Europe, and the Asia-Pacific region, and represents a unique approach in the development of future treatment options for this rare blood cancer.

This is an excellent opportunity to catch up on what you may have missed and to better understand the goals, structure, and potential impact of this promising clinical trial.

More translations in different languages will be made available soon to ensure wider accessibility. Stay tuned!